Amycretin, a novel unimolecular peptide agonist of GLP-1, amylin and calcitonin receptors, has demonstrated 24% weight loss (60 mg dose) at 36 weeks in a phase 1b/2a study and offers a promising oral formulation
Supplementing with glutathione can help
Liraglutide (Daily Injection) Liraglutide is an earlier GLP-1 medicine with long-term safety data
Available from: Molina-Lpez J, Florea D, Quintero-Osso B, de la Cruz AP, Rodrguez-Elvira M, Del Pozo EP
S., Masi, L., Giardina, G., Paulini, G., Malagrin, F
J Neurochem 18:513519 Calabrese V, Scapagnini G, Ravagna A, Fariello RG, Giuffrida Stella AM, Abraham NG (2002) Regional distribution of heme oxygenase, HSP70, and glutathione in brain: relevance for endogenous oxidant/antioxidant balance and stress tolerance